Company Profiles

driven by the PitchBook Platform

Gamida Cell

Description

Developer of curative cellular and immune therapies intended as treatments for cancer and orphan genetic diseases. The company's NAM technology increases the limited population and quality of stem and progenitor cells, helping to expand functional cells in culture and create unprecedented, life-saving cures for blood cancers such as leukemia and lymphoma and rare genetic diseases such as sickle cell disease and thalassemia.

1998

Founded

PRIVATE

Status

51-200

Employees

Grant

Latest Deal Type

$3.5M

Latest Deal Amount

$128M

Total Amount Raised

Description

Developer of curative cellular and immune therapies intended as treatments for cancer and orphan genetic diseases. The company's NAM technology increases the limited population and quality of stem and progenitor cells, helping to expand functional cells in culture and create unprecedented, life-saving cures for blood cancers such as leukemia and lymphoma and rare genetic diseases such as sickle cell disease and thalassemia.

Website:

www.gamida-cell.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

PO Box 34670 Jerusalem 91340Israel +972 (0)2 659 5666
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Gamida Cell's full profile, request a free trial.

Gamida Cell Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Gamida Cell Investors (16)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
AmgenVC-Backed CompanyMinority000 0000000 0000
Auriga PartnersVenture CapitalMinority000 0000000 0000
Biomedical InvestmentsVenture CapitalMinority000 0000000 0000
Bio-Technology GeneralCorporationMinority000 0000000 0000
Clal Biotechnology IndustriesVenture CapitalMinority000 0000000 0000
Amgen VC-Backed Company
Auriga Partners Venture Capital
Biomedical Investments Venture Capital
Bio-Technology General Corporation
Clal Biotechnology Industries Venture Capital

Gamida Cell Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Yael Margolin Ph.DChief Executive Officer, Board Member & President
Naftali BrikashviliChief Financial Officer
Tony PeledChief Scientific Officer, Vice President of Research & Development & Co-Founder
David SnyderVice President, Clinical Development and Regulatory Affairs
Dorit HaratiVice President, Quality Assurance, Manufacturing & Logistics
Yael Margolin Ph.D Chief Executive Officer, Board Member & President
Naftali Brikashvili Chief Financial Officer
Tony Peled Chief Scientific Officer, Vice President of Research & Development & Co-Founder
David Snyder Vice President, Clinical Development and Regulatory Affairs
Dorit Harati Vice President, Quality Assurance, Manufacturing & Logistics

Gamida Cell Board Members (10)

NameRepresentingRoleSinceContact
Info
Boaz LifschitzSelfBoard Member000 0000
Hadar Ron MDIsrael Healthcare VenturesManaging Partner & Executive, Investments000 0000
Julian Adams Ph.DClal Biotechnology IndustriesChief Science Officer & President000 0000
Kenneth MochSelfBoard Member000 0000
Michael Perry Ph.DSelfBoard Member000 0000
Boaz Lifschitz Board Member Self
Hadar Ron MD Managing Partner & Executive, Investments Israel Healthcare Ventures
Julian Adams Ph.D Chief Science Officer & President Clal Biotechnology Industries
Kenneth Moch Board Member Self
Michael Perry Ph.D Board Member Self
Request full access to PitchBook